SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-026037
Filing Date
2021-05-10
Accepted
2021-05-10 16:05:36
Documents
14
Period of Report
2021-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K allk-8k_20210510.htm   iXBRL 8-K 44563
2 EX-99.1 allk-ex991_6.htm EX-99.1 177018
3 GRAPHIC gdt12ft2krwj000001.jpg GRAPHIC 16725
  Complete submission text file 0001564590-21-026037.txt   384247

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA allk-20210510.xsd EX-101.SCH 5772
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE allk-20210510_lab.xml EX-101.LAB 19495
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE allk-20210510_pre.xml EX-101.PRE 11629
7 EXTRACTED XBRL INSTANCE DOCUMENT allk-8k_20210510_htm.xml XML 3536
Mailing Address 975 ISLAND DRIVE SUITE 201 REDWOOD CITY CA 94065
Business Address 975 ISLAND DRIVE SUITE 201 REDWOOD CITY CA 94065 650-597-5002
Allakos Inc. (Filer) CIK: 0001564824 (see all company filings)

IRS No.: 454798831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38582 | Film No.: 21907082
SIC: 2834 Pharmaceutical Preparations